BT062
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for BT062, covering 2013-07-18 to 2019-07-23. Get the full timeline:
Most recent: Clinical Trial Update: BT062 in Combination With Lenalidomide or Pomalidomide and Dexamethasone in Patients With Multiple Myeloma [Phase 1, Phase 2]